Abiopharma

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

Symbol	PACB
Name	PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Sector	INDUSTRIALS
Region	North America
Industry	Biotechnology: Laboratory Analytical Instruments
Address	1305 OBRIEN DRIVE, MENLO PARK, California, 94025, United States
Telephone	+1 650 - 521-8000
Fax	—
Email	—
Website	https://www.pacb.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001299130
Description	Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the companys revenue is derived from North America, followed by Asia and Europe. Additional info from NASDAQ: Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the companys revenue is derived from North America, followed by Asia and Europe.

2026-08-19 00:17

Van Oene Mark 🔴 sold 26.9K shares of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) at $1.13 Transaction Date: Aug 17, 2026 | Filing ID: 000128

2026-08-17 20:08

📋 MARK VAN OENE (Officer) plans to sell 27K shares of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (at $1.13 each, total $31K) Filed: Aug 17, 2026 | ID: 008204

2026-08-14 15:53

New Form SCHEDULE 13G/A - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Filed: 2026-08-14 AccNo: 0001104659-26-096937 Size: 13 KB

2026-08-11 21:54

Van Oene Mark 🟢 acquired 2.5M shares (1 derivative) of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) at $1.15 ($2.3M) Transaction Date: Aug 10, 2026 | Filing ID: 000126

2026-08-05 20:08

PacBio Appoints Mark Van Oene as President and Chief Executive Officer

2026-08-05 20:05

PacBio Announces Second Quarter 2026 Financial Results

2026-08-05 13:05

PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system

2026-07-28 20:05

PacBio to Participate in the Canaccord Genuity 46th Annual Growth Conference

2026-07-15 20:05

PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026

2026-06-04 21:27

Director MOHR MARSHALL 🟢 acquired 223.5K shares (1 derivative) of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) at $1.58 Transaction Date: Jun 03, 2026 | Filing ID: 000108